RFC3 and breast carcinoma: It indicates that the expression of RFC3 in ER-positive breast cancer TAM-resistant cells affects the migration ability of breast cancer cells, and the migration ability of breast cancer cells was enhanced when RFC3 was overexpressed, while the migration ability of breast cancer resistant cells was reduced after RFC3 was knocked down.